Main Management ETF Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$963K Buy
2025
Q1
$662K Buy
2024
Q4
$532K Sell
2024
Q3
$693K Buy